TCG Crossover Management, LLC
CIK 1839948 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $4.2B
- Posisi
- 54
- Per tanggal
- 30 Juni 2026
#915 dari 9.443 berdasarkan nilai 13F · top 9.7%
Nilai portofolio QoQ: +19.0% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 57,45%
- Bobot 25 kepemilikan teratas
- 85,79%
- Posisi di atas 1%
- 26
- Jumlah posisi efektif
- 16,2
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 12,41% Perkiraan pembelian $475.122.092 · penjualan $492.418.484
Kepemilikan median: 3,0 kuartal Dilacak Q4 2024–Q2 2026 · 64,3% masih dipegang
- Posisi baru
- 12
- Meningkat
- 2
- Menurun
- 9
- Tertutup
- 7
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +134.0% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 97,8% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
96,5%
Lainnya/Tidak terpetakan
3,5%
Portofolio lengkap 54 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| ABVX Abivax SA - American Depositary Shares | $800.603.959 | 19,24% | 6.007.834 | $78.935.144 | Turun ×2 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $283.878.343 | 6,82% | 9.081.201 | $63.568.338 | Turun ×2 | ||
| CGON CG Oncology, Inc. - Common stock | $260.768.136 | 6,27% | 3.670.206 | $12.368.594 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $187.866.673 | 4,52% | 4.854.436 | $-2.539.277 | Turun ×4 | ||
| IMVT Immunovant, Inc. - Common Stock | $171.766.278 | 4,13% | 4.457.988 | $61.029.856 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $168.733.670 | 4,06% | 1.900.582 | $72.868.314 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $163.437.308 | 3,93% | 1.676.624 | $22.735.022 | |||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $124.334.076 | 2,99% | 1.062.049 | $26.221.989 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $116.614.913 | 2,80% | 6.137.627 | Naik ×1 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $112.138.864 | 2,70% | 6.243.812 | $25.349.877 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $111.856.054 | 2,69% | 4.622.151 | $35.821.670 | |||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $110.209.680 | 2,65% | 11.020.968 | $5.290.065 | |||
| VOR Vor Biopharma Inc. - Common Stock | $104.441.366 | 2,51% | 5.673.078 | $7.942.314 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $103.772.421 | 2,49% | 3.248.980 | $-20.663.513 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $102.502.348 | 2,46% | 4.615.144 | $18.829.787 | |||
| IRON Disc Medicine, Inc. - Common Stock | $98.143.787 | 2,36% | 1.341.862 | $12.345.131 | |||
| RLAY Relay Therapeutics, Inc. - Common Stock | $79.954.491 | 1,92% | 4.273.356 | $37.434.599 | |||
| SVRA Savara, Inc. - Common Stock | $76.151.183 | 1,83% | 12.362.205 | $8.653.544 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $67.686.664 | 1,63% | 9.533.333 | Naik ×1 | |||
| RVMD Revolution Medicines, Inc. - Common Stock | $63.843.565 | 1,53% | 340.899 | $7.781.566 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: 337185102) | $58.253.516 | 1,40% | 2.895.304 | Naik ×1 | |||
| KOD Kodiak Sciences Inc - Common Stock | $56.318.161 | 1,35% | 1.445.538 | $1.214.253 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $55.756.378 | 1,34% | 3.017.120 | $44.732.320 | Naik ×2 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $46.972.446 | 1,13% | 1.447.310 | $1.692.835 | Turun ×1 | ||
| IPSC Century Therapeutics, Inc. - Common Stock | $43.401.690 | 1,04% | 17.754.430 | $4.380.116 | |||
| TECX Tectonic Therapeutic, Inc. - Common Stock | $41.418.128 | 1,00% | 1.204.891 | $4.174.947 | |||
| XNCR Xencor, Inc. - Common Stock | $39.479.422 | 0,95% | 2.452.138 | $9.906.638 | |||
| SRZN Surrozen, Inc. - Common Stock | $38.226.971 | 0,92% | 1.473.101 | $-4.684.461 | |||
| EDIT Editas Medicine, Inc. - Common Stock | $36.000.000 | 0,87% | 11.111.111 | Naik ×1 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $35.880.000 | 0,86% | 650.000 | $16.477.500 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $34.864.559 | 0,84% | 1.008.229 | Naik ×1 | |||
| SLN Silence Therapeutics Plc - American Depository Share | $33.308.489 | 0,80% | 3.033.560 | $17.321.628 | |||
| IFRX InflaRx N.V. - Common Stock | $32.480.000 | 0,78% | 14.500.000 | Naik ×1 | |||
| ALT Altimmune, Inc. - Common Stock | $30.400.000 | 0,73% | 10.000.000 | Naik ×1 | |||
| JANX Janux Therapeutics, Inc. - Common Stock | $27.488.517 | 0,66% | 1.789.617 | $2.612.841 | |||
| CATX | $26.992.083 | 0,65% | 7.915.567 | $-6.015.831 | |||
| AGMB AgomAb Therapeutics NV - ADRs representing one common share. | $26.650.964 | 0,64% | 2.053.233 | $5.112.550 | |||
| BHVN Biohaven Ltd. Common Shares | $26.485.686 | 0,64% | 1.779.952 | $-12.695.256 | Turun ×1 | ||
| AKTS Aktis Oncology, Inc. - Common stock | $22.450.129 | 0,54% | 696.560 | Naik ×1 | |||
| ALEC Alector, Inc. - Common Stock | $20.100.000 | 0,48% | 10.000.000 | $-1.400.000 | |||
| FBRX Forte Biosciences, Inc. - Common Stock | $19.550.000 | 0,47% | 920.000 | Naik ×1 | |||
| MNPR Monopar Therapeutics Inc. - Common Stock | $18.826.047 | 0,45% | 203.327 | $11.588.124 | Naik ×1 | ||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $16.180.925 | 0,39% | 1.647.752 | $2.224.466 | |||
| ADCT ADC Therapeutics SA Common Shares | $12.187.487 | 0,29% | 11.390.175 | $-30.525.669 | |||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $11.706.858 | 0,28% | 5.655.487 | $-14.381.899 | Turun ×1 | ||
| TRDA Entrada Therapeutics, Inc. - Common Stock | $7.803.293 | 0,19% | 1.060.230 | $-21.064.957 | Turun ×1 | ||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $7.407.573 | 0,18% | 406.786 | $1.627.144 | |||
| ARVN Arvinas, Inc. - Common Stock | $5.875.984 | 0,14% | 707.098 | $-19.431.103 | Turun ×2 | ||
| KRRO Korro Bio, Inc. - Common Stock | $5.486.847 | 0,13% | 416.301 | $774.320 | |||
| Penerbit tidak dikenal (CUSIP: G75226103) | $5.350.000 | 0,13% | 500.000 | Naik ×1 | |||
| LONA LeonaBio, Inc. - Common Stock | $4.267.818 | 0,10% | 464.398 | $-398.778 | |||
| Penerbit tidak dikenal (CUSIP: G50765109) | $2.272.000 | 0,05% | 200.000 | Naik ×1 | |||
| CNTX Context Therapeutics Inc. - Common Stock | $1.485.945 | 0,04% | 2.682.696 | $-5.542.719 | |||
| EIKN Eikon Therapeutics, Inc. - Common Stock | $494.621 | 0,01% | 37.902 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ZLAB | $116.614.913 | 6.137.627 | 2,80% |
| AURA | $67.686.664 | 9.533.333 | 1,63% |
| Penerbit tidak dikenal (CUSIP: 337185102) | $58.253.516 | 2.895.304 | 1,40% |
| EDIT | $36.000.000 | 11.111.111 | 0,87% |
| PHVS | $34.864.559 | 1.008.229 | 0,84% |
| IFRX | $32.480.000 | 14.500.000 | 0,78% |
| ALT | $30.400.000 | 10.000.000 | 0,73% |
| AKTS | $22.450.129 | 696.560 | 0,54% |
| FBRX | $19.550.000 | 920.000 | 0,47% |
| Penerbit tidak dikenal (CUSIP: G75226103) | $5.350.000 | 500.000 | 0,13% |
| Penerbit tidak dikenal (CUSIP: G50765109) | $2.272.000 | 200.000 | 0,05% |
| EIKN | $494.621 | 37.902 | 0,01% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| ABVX | Dipangkas | -473K | +$78.9M |
| SYRE | Hanya pergerakan harga | +0 | +$72.9M |
| TNGX | Dipangkas | -1.4M | +$63.6M |
| IMVT | Hanya pergerakan harga | +0 | +$61.0M |
| RLAY | Hanya pergerakan harga | +0 | +$37.4M |
| GLUE | Hanya pergerakan harga | +0 | +$35.8M |
| ADCT | Hanya pergerakan harga | +0 | -$30.5M |
| MIRM | Hanya pergerakan harga | +0 | +$26.2M |
| AMLX | Hanya pergerakan harga | +0 | +$25.3M |
| DNTH | Hanya pergerakan harga | +0 | +$22.7M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| CNTA | 30 Juni 2026 | 4.286.480 | $170.258.986 | Tidak lagi dilacak |
| RAPT | 31 Maret 2026 | 2.582.408 | $87.466.159 | Tidak lagi dilacak |
| EYPT | 31 Maret 2026 | 3.572.335 | $65.266.560 | -53,8% |
| TRML | 31 Des. 2025 | 1.311.783 | $62.742.581 | Tidak lagi dilacak |
| CDTX | 30 Sep. 2025 | 1.005.901 | $48.997.438 | Tidak lagi dilacak |
| FULC | 30 Juni 2026 | 5.250.000 | $40.267.500 | 7,2% |
| MLYS | 30 Juni 2025 | 2.470.265 | $39.227.808 | 102,0% |
| AGIO | 31 Maret 2026 | 1.181.841 | $32.169.712 | 4,7% |
| IRON | 31 Des. 2025 | 465.257 | $30.744.183 | 1,8% |
| ATXS | 31 Des. 2025 | 2.761.861 | $20.106.348 | Tidak lagi dilacak |
| SLNO | 30 Sep. 2025 | 186.250 | $15.604.025 | Tidak lagi dilacak |
| LQDA | 30 Juni 2026 | 403.048 | $15.211.032 | -7,4% |
| CMPS | 30 Juni 2025 | 3.858.000 | $11.033.880 | 397,9% |
| THRD | 30 Sep. 2025 | 1.915.424 | $10.400.752 | Tidak lagi dilacak |
| ELVN | 30 Sep. 2025 | 498.000 | $9.989.880 | 188,1% |
| KROS | 31 Maret 2025 | 550.000 | $8.706.500 | 6,6% |
| ADVM | 31 Des. 2025 | 1.668.174 | $7.556.828 | Tidak lagi dilacak |
| URGN | 30 Juni 2026 | 405.365 | $7.288.463 | 34,6% |
| MAZE | 31 Maret 2026 | 173.816 | $7.201.197 | -0,3% |
| NKTR | 30 Sep. 2025 | 266.666 | $6.890.649 | 33,4% |
| GPCR | 30 Juni 2026 | 140.411 | $6.767.810 | 0,0% |
| AVTE | 30 Juni 2025 | 2.240.809 | $5.624.431 | Tidak lagi dilacak |
| PEPG | 31 Des. 2025 | 1.200.000 | $5.544.000 | -55,5% |
| KURA | 30 Sep. 2025 | 735.184 | $4.242.012 | 43,8% |
| VTYX | 31 Maret 2026 | 316.195 | $2.855.241 | Tidak lagi dilacak |
| UPB | 30 Juni 2026 | 181.063 | $1.629.567 | 1,6% |
| VTGN | 30 Juni 2026 | 2.676.580 | $1.529.665 | 5,2% |
| JBIO | 30 Sep. 2025 | 64.023 | $639.590 | 168,8% |
| CABA | 30 Sep. 2025 | 86.795 | $131.928 | 37,0% |